Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Aarey Drugs & Pharmaceuticals Ltd Financial Statements & Historical Data

Updated NSE: AAREYDRUGSBSE: 524412
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 1 October 2026, 9:46 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price104₹ per share
Reported P/E77.1Times
Book value per share53.0₹ per share
Reported ROCE5.58 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 1 October 2026, 9:46 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap321 Cr.
Current Price104
High / Low108/50.3
Stock P/E77.1
Book Value53.0
Dividend Yield0.00 %
ROCE5.58 %
ROE2.75 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Aarey Drugs & Pharmaceuticals Ltd 321 Cr. 104 108/50.377.1 53.00.00 %5.58 %2.75 % 10.0
Lyka Labs Ltd 292 Cr. 81.6 105/44.1 25.90.00 %5.98 %10.2 % 10.0
SMS Lifesciences India Ltd 357 Cr. 1,197 1,680/95620.6 6500.13 %11.8 %10.8 % 10.0
BDH Industries Ltd 278 Cr. 482 610/34023.7 1341.04 %20.5 %14.8 % 10.0
Gennex Laboratories Ltd 238 Cr. 9.80 17.2/7.0512.7 9.160.00 %11.8 %10.5 % 1.00
Industry Average17,560.90 Cr1,250.1654.88211.240.39%26.16%16.59%6.06

All Competitor Stocks of Aarey Drugs & Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 50.9657.8376.48210.35126.91105.14133.79108.10102.2184.1696.43189.4744.63
Expenses 49.6255.9973.78211.79125.73101.42131.59112.31100.5081.5297.94185.1343.31
Operating Profit 1.341.842.70-1.441.183.722.20-4.211.712.64-1.514.341.32
OPM % 2.63%3.18%3.53%-0.68%0.93%3.54%1.64%-3.89%1.67%3.14%-1.57%2.29%2.96%
Other Income 0.700.840.295.141.580.020.687.541.550.794.18-0.431.72
Interest 0.420.410.470.400.960.490.581.301.041.260.921.781.67
Depreciation 0.891.271.061.150.471.510.900.410.490.690.830.850.85
Profit before tax 0.731.001.462.151.331.741.401.621.731.480.921.280.52
Tax % 0.00%-22.00%30.14%-0.47%6.77%8.62%48.57%71.60%20.81%31.08%38.04%-21.88%-98.08%
Net Profit 0.721.231.022.151.241.600.720.471.371.020.571.561.02
EPS in Rs 0.280.480.400.770.440.570.250.170.480.360.200.550.36

Last Updated: September 29, 2026, 4:33 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 29, 2026, 10:17 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 200213246396349354298348493419396474472415
Expenses 198212245386342347294344481411391471465408
Operating Profit 1111088351184377
OPM % 1%0.6%0.4%2.4%2.2%2.2%1.1%1.3%2.3%1.8%1.1%0.6%1.5%1.6%
Other Income 233334773371066
Interest 11242222234556
Depreciation 11111111222233
Profit before tax 112889781065654
Tax % 22%23%29%31%25%27%20%21%35%37%12%34%27%
Net Profit 11156767745444
EPS in Rs 0.620.650.773.022.642.802.482.782.581.491.671.421.401.47
Dividend Payout % 0%0%0%0%0%4%0%0%0%0%0%0%0%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)0.00%0.00%400.00%20.00%16.67%-14.29%16.67%0.00%-42.86%25.00%-20.00%0.00%
Change in YoY Net Profit Growth (%)0.00%0.00%400.00%-380.00%-3.33%-30.95%30.95%-16.67%-42.86%67.86%-45.00%20.00%

Aarey Drugs & Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:10%
3 Years:-1%
TTM:-5%
Compounded Profit Growth
10 Years:14%
5 Years:-7%
3 Years:-15%
TTM:-26%
Stock Price CAGR
10 Years:18%
5 Years:16%
3 Years:20%
1 Year:-3%
Return on Equity
10 Years:6%
5 Years:4%
3 Years:3%
Last Year:3%

Last Updated: September 5, 2025, 2:01 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 29, 2026, 10:17 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 171718232323232525282828
Reserves 192031576369758892105110122
Borrowings 11151031618181438313550
Other Liabilities 69748386438411611713613911797
Total Liabilities 115125142170146194233245291303291297
Fixed Assets 6812121212141414131626
CWIP 000000000000
Investments 000000000122
Other Assets 109117130157133181218230277289272269
Total Assets 115125142170146194233245291303291297
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 361-201350-1-31010
Cash from Investing Activity + -2-3-5-1-1-1-3-30-2-6-12
Cash from Financing Activity + -2-2423-2-2-2216-42
Net Cash Flow -11-12-300-011-0-0
Free Cash Flow 13-4-21-123-2-2-45-2
CFO/OP 239%560%28%-232%37%135%154%36%13%-37%421%164%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow1.003.00-4.00-21.00-1.002.003.00-2.00-2.00-4.005.00-2.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 11911410875100109118170101165170103
Inventory Days 107351623212011263336
Days Payable 119117108718440981208611512381
Cash Conversion Cycle 95393292426926768058
Working Capital Days 5249403469779991688910689
ROCE %6%7%7%22%14%12%8%9%10%6%6%6%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 50.04%50.04%45.28%45.28%45.44%44.80%44.80%44.80%44.80%39.05%37.71%37.71%
FIIs 3.94%3.83%3.40%3.40%2.75%2.34%2.34%1.97%1.13%3.86%4.18%4.81%
DIIs 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.62%1.62%
Public 46.01%46.12%51.31%51.32%51.81%52.86%52.86%53.23%54.07%57.09%56.49%55.87%
No. of Shareholders 16,08615,26916,84316,17916,67616,28816,25715,79614,89714,06314,18813,478

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 1.421.671.492.722.79
Diluted EPS (Rs.) 1.421.671.492.722.79
Cash EPS (Rs.) 2.102.272.113.363.18
Book Value[Excl.RevalReserv]/Share (Rs.) 48.6747.3346.2544.7742.27
Book Value[Incl.RevalReserv]/Share (Rs.) 48.6747.3346.2544.7742.27
Revenue From Operations / Share (Rs.) 166.56141.02165.04194.09148.99
PBDIT / Share (Rs.) 4.474.074.125.524.98
PBIT / Share (Rs.) 3.783.463.504.744.59
PBT / Share (Rs.) 2.141.902.373.953.55
Net Profit / Share (Rs.) 1.411.671.492.582.79
PBDIT Margin (%) 2.682.882.492.843.34
PBIT Margin (%) 2.272.452.112.443.08
PBT Margin (%) 1.281.351.432.032.38
Net Profit Margin (%) 0.841.180.901.321.86
Return on Networth / Equity (%) 2.903.523.215.756.58
Return on Capital Employeed (%) 7.617.107.2010.4410.68
Return On Assets (%) 1.381.541.292.662.79
Long Term Debt / Equity (X) 0.010.020.030.000.00
Total Debt / Equity (X) 0.250.230.320.120.18
Asset Turnover Ratio (%) 1.601.331.562.061.63
Current Ratio (X) 1.781.701.611.741.65
Quick Ratio (X) 1.481.491.441.631.51
Inventory Turnover Ratio (X) 11.830.000.000.000.00
Interest Coverage Ratio (X) 2.732.613.657.014.79
Interest Coverage Ratio (Post Tax) (X) 1.862.072.324.273.68
Enterprise Value (Cr.) 129.30155.1097.10119.0671.62
EV / Net Operating Revenue (X) 0.270.390.230.240.20
EV / EBITDA (X) 10.1713.599.298.506.15
MarketCap / Net Operating Revenue (X) 0.200.310.140.210.15
Price / BV (X) 0.690.940.510.920.54
Price / Net Operating Revenue (X) 0.200.310.140.210.15
EarningsYield 0.040.030.060.060.12
Advertisements
Explore Industry-wise Company financial data